Literature DB >> 24483194

Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.

Barry D Liboiron1, Lawrence D Mayer.   

Abstract

While combination chemotherapy has led to measurable improvements in cancer treatment outcomes, its full potential remains to be realized. Nanoscale particles such as liposomes, nanoparticles and polymer micelles have been shown to increase delivery to the tumor site while bypassing many drug resistance mechanisms that limit the effectiveness of conventional therapies. Recent efforts in drug delivery have focused on coordinated, controlled delivery of multiple anticancer agents encapsulated within a single particle system. In this review, we analyze recent progress made in multidrug delivery in three main areas of interest: co-delivery of antineoplastic agents with drug sensitizers, sequential delivery via temporal release particles and simultaneous delivery of multiple agents. Future directions of the field, in light of recent advances with molecularly targeted agents, are suggested and discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24483194     DOI: 10.4155/tde.13.149

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  11 in total

Review 1.  Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.

Authors:  Fanfei Meng; Ning Han; Yoon Yeo
Journal:  Expert Opin Drug Deliv       Date:  2016-08-08       Impact factor: 6.648

2.  Advanced Nanoengineering Approach for Target-Specific, Spatiotemporal, and Ratiometric Delivery of Gemcitabine-Cisplatin Combination for Improved Therapeutic Outcome in Pancreatic Cancer.

Authors:  Mubin Tarannum; Md Akram Hossain; Bryce Holmes; Shan Yan; Pinku Mukherjee; Juan L Vivero-Escoto
Journal:  Small       Date:  2021-11-10       Impact factor: 13.281

3.  Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity.

Authors:  Jonathan C Barnes; Peter M Bruno; Hung V-T Nguyen; Longyan Liao; Jenny Liu; Michael T Hemann; Jeremiah A Johnson
Journal:  J Am Chem Soc       Date:  2016-09-14       Impact factor: 15.419

Review 4.  Positron emission tomography image-guided drug delivery: current status and future perspectives.

Authors:  Rubel Chakravarty; Hao Hong; Weibo Cai
Journal:  Mol Pharm       Date:  2014-06-04       Impact factor: 4.939

Review 5.  Nanotechnology in oral cancer: A comprehensive review.

Authors:  Monika Poonia; Karthikeyan Ramalingam; Sandeep Goyal; Supreet Kaur Sidhu
Journal:  J Oral Maxillofac Pathol       Date:  2017 Sep-Dec

Review 6.  Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy.

Authors:  Mathangi Srinivasan; Mehdi Rajabi; Shaker A Mousa
Journal:  Nanomaterials (Basel)       Date:  2015-10-14       Impact factor: 5.076

Review 7.  Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence.

Authors:  Shian-Ren Lin; Chia-Hsiang Chang; Che-Fang Hsu; May-Jwan Tsai; Henrich Cheng; Max K Leong; Ping-Jyun Sung; Jian-Chyi Chen; Ching-Feng Weng
Journal:  Br J Pharmacol       Date:  2019-11-27       Impact factor: 8.739

Review 8.  Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.

Authors:  Shizhu Chen; Keni Yang; Ruslan G Tuguntaev; Anbu Mozhi; Jinchao Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanomedicine       Date:  2015-12-17       Impact factor: 5.307

Review 9.  Synthetic lethality in lung cancer and translation to clinical therapies.

Authors:  Ada W Y Leung; Tanya de Silva; Marcel B Bally; William W Lockwood
Journal:  Mol Cancer       Date:  2016-09-29       Impact factor: 27.401

10.  Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles.

Authors:  Jie Gao; Junjie Liu; Fangyuan Xie; Ying Lu; Chuan Yin; Xian Shen
Journal:  Int J Nanomedicine       Date:  2019-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.